Alder Hey Childrens NHS Foundation Trust
Liverpool L14 5AB
3 studies enrolling now · 18 studies all time
What they study most
Alport Syndrome, Alport Syndrome, Autosomal Recessive, Alport Syndrome, X-Linked, Anemia, Autoimmune Diseases, COVID-19, Cushing Syndrome, Cystic Fibrosis, Diabetes Mellitus, Diabetes Mellitus, Type 1, Duchenne Muscular Dystrophy, Endocrine System Diseases
Studies at this site
- EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety — Recruiting now
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes — Recruiting now
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases — Recruiting now
- Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome — Recruiting now
- Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older — Completed
- Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years — Completed
- Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 — Stopped early
- An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy — Stopped early
- Study of Remdesivir in Participants Below 18 Years Old With COVID-19 — Completed
- Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years — Completed
- A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) — Completed
- Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis — Completed
- Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis — Completed
- IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity — Completed
- Day and Night Closed-loop in Young People With Type 1 Diabetes — Completed
- A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy — Stopped early
- Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD) — Stopped early
- A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis — Completed